microdosing semaglutide for perimenopause GLP-1 Perimenopause: Why Lower Doses Might Be Better People Are Microdosing Weight-Loss Drugs

In addition, although numerous strategies for managing these AEs have been described, their application in clinical practice continues to evolve

Thus, the effectiveness of the product is reduced, and patients cannot get the desired effect, which may potentially be dangerous (for example, people may experience sudden blood sugar spikes)

A dose that works for someone else might be too much or too little for you

No scrambling to find cooling solutions at the last minute

Avoid using ice cubes, as freezing could damage the medication

Tirzepatide (Mounjaro, Zepbound) works similarly but is technically a dual GIP/GLP-1 receptor agonist rather than a pure GLP-1 medication